Purchase Order 36C26326P0165
- Not listed
- Edwards Lifesciences LLC, a leading manufacturer of advanced cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on October 20, 2025, with an ultimate completion date of November 19, 2025. The contract, which carries no set-aside designation, covers transcatheter aortic valve replacement (TAVR) equipment to be delivered to the Minneapolis, Minnesota VA facility. As a subsidiary of Edwards Lifesciences...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of advanced cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 for specialized transcatheter aortic valve replacement (TAVR) products. The contract, awarded on June 9, 2025, with a completion date of June 11, 2025, is for delivery to Minneapolis, Minnesota. No set-aside designation was applied to this award, and...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota. This award represents no set-aside designation and reflects the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) medical devices. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed in Minneapolis, Minnesota. This award represents a direct...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical device innovation, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on November 7, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota with an ultimate completion date of November 10, 2025. This award carries no set-aside designation and...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order on December 8, 2025, by Veterans Integrated Service Network (VISN) 23 for TAVR (transcatheter aortic valve replacement) equipment and related products. The contract, with a ceiling value of $34,000, has an ultimate completion date of December 10, 2025, and will be performed in Minneapolis, Minnesota. No set-aside...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of advanced cardiovascular medical devices, has been awarded a firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) equipment. The contract, awarded on September 19, 2025, carries a ceiling value of $34,000 and an ultimate completion date of September 22, 2025, with performance to be fulfilled in Minneapolis, Minnesota....
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (VISN 23) on December 12, 2025. The contract, classified as a transcatheter aortic valve replacement (TAVR) procurement, has an ultimate completion date of December 15, 2025 and will be performed in Minneapolis, Minnesota. This award represents a non-competitive,...
- Edwards Lifesciences LLC, a leading developer of advanced cardiovascular medical devices, was awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network 23 (VISN 23) on November 21, 2025, with an ultimate completion date of November 24, 2025. This contract, which received no set-aside designation, is classified as a Purchase Order under the contract type structure. The award supports the VA's mission to provide specialized medical equipment for veteran...
Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network (VISN) 23, a civilian component of the U.S. Department of Veterans Affairs, on December 19, 2025. The contract, which has no set-aside designation, is for TAVR (Transcatheter Aortic Valve Replacement) devices and will be performed in Minneapolis, Minnesota, with an ultimate completion date of December 22, 2025. As a subsidiary of Edwards Lifesciences Corporation and a recognized small disadvantaged business, Edwards Lifesciences LLC is a leading provider of advanced cardiovascular medical devices to the VA healthcare system. This purchase order represents a continuation of Edwards Lifesciences LLC's ongoing role as the primary supplier of specialized cardiac technologies to the VA. The company maintains significant indefinite delivery contracts with the VA, including a $2.5 million agreement through VISN 10 and a $1.25 million contract with the VA Ann Arbor Healthcare System, both supporting consignment and on-demand procurement of advanced heart valve products. The short timeline for this award indicates an urgent clinical need for transcatheter heart valve technology at the Minneapolis VISN facility to support veteran cardiac care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 12/19/25 |